Rpg Investment Advisory, LLC Biogen Inc. Transaction History

Rpg Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 06, 2018	SELL	$257.52 - $306.91 $507,829 - $605,226	-1,972 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $65,292 - $92,345	-251 Reduced 11.29%	1,972 $540,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $69,526 - $77,875	-226 Reduced 9.23%	2,223 $708,000
Q3 2017 Feb 05, 2019	SELL	$281.15 - $329.69 $77,035 - $90,335	-274 Reduced 10.06%	2,449 $767,000
Q2 2017 Feb 04, 2019	BUY	N/A	2,723	2,723 $739,000

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rpg Investment Advisory, LLC with notifications on news.